BioPharm International
July 01, 2013
From the Editor
26
7
Pharma and biotech companies, with the rest of the healthcare industry, must face change.
July 01, 2013
Features
26
7
Industry experts discuss the implementation of QbD and PAT tools in biopharmaceutical manufacturing.
July 01, 2013
European Beat
26
7
European governments are under pressure to take regulatory action, but solving the problem of medicine shortages is not as straightforward as it seems.
July 01, 2013
Boot Camp Business Guide
26
7
Five key attributes to look for in a biopharm training partner.
July 01, 2013
Global News
26
7
Brazil offers opportunities and challenges for global pharmaceutical companies.
July 01, 2013
Perspectives on Outsourcing
26
7
The industry may not be ready for India and China as regulatory issues emerge.
July 01, 2013
Analytical Best Practices
26
7
The author discusses the need for stability analysis.
July 01, 2013
Features
26
7
An analytical method assesses the effects of media condition on cultured antibodies.
July 01, 2013
Regulatory Beat
26
7
Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.
July 01, 2013
Burrill on Biotech
26
7
Biotech companies raise most money in 13 years.
July 01, 2013
Features
26
7
Traditional project decision-making vs. a QbD approach.
July 01, 2013
Issue PDF
26
7
Click the title above to open the BioPharm International July 2013 issue in an interactive PDF format.